Could a common pill help prevent aortic rupture?
NCT ID NCT07483177
First seen Mar 20, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study tests whether spironolactone, a medication often used for heart failure, can reduce stiffness in the aorta (the main artery) in people with a thoracic aortic aneurysm. The goal is to see if it can help control the disease and lower the risk of dangerous complications. Fifty adults with an enlarged aorta will receive either spironolactone or a placebo for a short period, and researchers will measure changes in artery stiffness and blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THORACIC AORTIC ANEURYSM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.